Novo Nordisk Financials 2024 Investor Presentation

Novo Nordisk presented its 2024 financial strategy and strategic aspirations, including diabetes leadership, obesity sales targets exceeding 25 billion DKK by 2025, and rare disease advancement. The presentation outlines commercial execution priorities, innovation roadmap across diabetes and obesity treatment solutions, and ESG commitments alongside financial growth objectives.